NATURE’S SUNSHINE PRODUCTS, INC. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 525.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-06-30 was 525.00K shares, a 6.25% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-03-31 was 407.00K shares, a 13.06% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-09-30 was 396.00K shares, a 4.76% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-06-30 was 560.00K shares, a 18.64% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2025 was 463.00K shares, a 2.11% decline from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2024 was 473.00K shares, a 18.25% increase from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2023 was 400.00K shares.
- NATURE’S SUNSHINE PRODUCTS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month |
|---|---|---|---|---|
| 2026-06-30 | 525.00K shares 10-Q · filed 2026-08-06 | 336.00K shares 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 407.00K shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 463.00K shares 10-K · filed 2026-03-10 | |||
| 2025-09-30 | 396.00K shares 10-Q · filed 2025-11-06 | 389.00K shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 560.00K shares 10-Q · filed 2026-08-06 | 386.00K shares 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 360.00K shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 473.00K shares 10-K · filed 2026-03-10 | |||
| 2024-09-30 | 378.00K shares 10-Q · filed 2025-11-06 | 454.00K shares 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | 472.00K shares 10-Q · filed 2025-07-31 | 447.00K shares 10-Q · filed 2025-07-31 | ||
| 2024-03-31 | 396.00K shares 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | 400.00K shares 10-K · filed 2025-03-11 | |||
| 2023-09-30 | 359.00K shares 10-Q · filed 2024-11-07 | 357.00K shares 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | 454.00K shares 10-Q · filed 2024-08-08 | 387.00K shares 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 372.00K shares 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-12 | |||
| 2022-09-30 | 284.00K shares 10-Q · filed 2023-11-07 | 0.00 shares 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | 208.00K shares 10-Q · filed 2023-08-09 | 0.00 shares 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | 469.00K shares 10-K · filed 2023-03-16 | |||
| 2021-09-30 | 481.00K shares 10-Q · filed 2022-11-03 | 396.00K shares 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | 504.00K shares 10-Q · filed 2022-08-09 | 443.00K shares 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | 442.00K shares 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | 431.00K shares 10-K · filed 2022-03-08 | |||
| 2020-09-30 | 326.00K shares 10-Q · filed 2021-11-04 | 327.00K shares 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | 292.00K shares 10-Q · filed 2021-08-05 | 253.00K shares 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | 136.00K shares 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | 349.00K shares 10-K · filed 2021-03-10 | |||
| 2019-09-30 | 349.00K shares 10-Q · filed 2020-11-09 | 327.00K shares 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | 311.00K shares 10-Q · filed 2020-08-06 | 316.00K shares 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 317.00K shares 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-11 | |||
| 2018-09-30 | 218.00K shares 10-Q · filed 2019-11-07 | 312.00K shares 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | 297.00K shares 10-Q · filed 2019-08-09 | 350.00K shares 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | 343.00K shares 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-08 | |||
| 2017-09-30 | 389.00K shares 10-Q · filed 2018-11-08 | 392.00K shares 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-08 | 390.00K shares 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | 415.00K shares 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | 325.00K shares 10-K · filed 2019-03-08 | |||
| 2016-09-30 | 504.00K shares 10-Q · filed 2017-11-09 | 272.00K shares 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | 217.00K shares 10-Q · filed 2017-08-09 | 238.00K shares 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | 436.00K shares 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | 521.00K shares 10-K · filed 2018-03-16 | |||
| 2015-09-30 | 429.00K shares 10-Q · filed 2016-11-09 | 515.00K shares 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | 524.00K shares 10-Q · filed 2016-08-09 | 486.00K shares 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | 571.00K shares 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | 533.00K shares 10-K · filed 2017-03-14 | |||
| 2014-09-30 | 502.00K shares 10-Q · filed 2015-11-06 | 505.00K shares 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | 37.00K shares 10-Q · filed 2015-08-10 | 209.00K shares 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | 439.00K shares 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | 393.00K shares 10-K · filed 2016-03-14 | |||
| 2013-09-30 | 422.00K shares 10-Q · filed 2014-11-06 | 397.00K shares 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | 216.00K shares 10-Q · filed 2014-08-07 | 219.00K shares 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | 134.00K shares 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | 339.00K shares 10-K · filed 2015-03-13 | |||
| 2012-09-30 | 343.00K shares 10-Q · filed 2013-11-08 | 314.00K shares 10-Q · filed 2013-11-08 | ||
| 2012-06-30 | 259.00K shares 10-Q · filed 2013-08-09 | 362.00K shares 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | 268.00K shares 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | 145.00K shares 10-K · filed 2014-03-17 | |||
| 2011-09-30 | 130.00K shares 10-Q · filed 2012-11-06 | |||
| 2011-06-30 | 123.00K shares 10-Q · filed 2012-08-03 | 56.00K shares 10-Q · filed 2012-08-03 | ||
| 2010-12-31 | 90.00K shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |